{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:13Z","timestamp":1792097353424,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jvs.2026.08.037","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:47:51Z","timestamp":1789516071000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular Quality Initiative-based risk score for mortality within 3 years of revascularization for chronic limb-threatening ischemia in end-stage renal disease patients on dialysis"],"prefix":"10.1016","author":[{"given":"Paula Pinto","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2590-5960","authenticated-orcid":false,"given":"Jericho","family":"Hallare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Maisuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Akhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Darman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trissa","family":"Babrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Aulivola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-9791","authenticated-orcid":false,"given":"Matthew","family":"Blecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2026.08.037_bib1","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1016\/j.jvs.2018.08.169","article-title":"Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization","volume":"69","author":"Simons","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2026.1702848","article-title":"Factors associated with all-cause mortality in endovascularly treated patients with chronic limb-threatening ischemia","volume":"6","author":"Ra\u0161iov\u00e1","year":"2026","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.jvs.2026.08.037_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global Vascular Guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2026.08.037_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2026.08.037_bib6","article-title":"HMG CoA reductase inhibitors (statins) for dialysis patients","volume":"2013","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2026.08.037_bib7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2026.08.037_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvs.2026.08.037_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/postgradmedj-2019-137292","article-title":"Impact of statin on long-term outcome among patients with end-stage renal disease with acute myocardial infarction (AMI): a nationwide case-control study","volume":"97","author":"Kuo","year":"2021","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jvs.2026.08.037_bib10","first-page":"755","article-title":"Protective effects of statins on limb and cardiovascular outcomes in patients with peripheral artery disease and end-stage renal disease","volume":"39","author":"Lu","year":"2023","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jvs.2026.08.037_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.jvca.2008.11.005","article-title":"Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery","volume":"23","author":"Huffmyer","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jvs.2026.08.037_bib12","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1016\/j.ijcard.2013.07.115","article-title":"The beneficial effects of statins in patients undergoing hemodialysis","volume":"168","author":"Huang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvs.2026.08.037_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jvs.2021.04.067","article-title":"Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia","volume":"74","author":"Ramanan","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib15","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2026.08.037_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jvs.2025.03.177","article-title":"The impact of postoperative dual antiplatelet therapy on outcomes of endovascular therapies in patients with chronic limb-threatening ischemia in the Vascular Quality initiative-medicare-linked database","volume":"82","author":"Zarrintan","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib17","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvs.2026.08.037_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ckj\/sfac263","article-title":"Risks and outcomes of critical limb ischemia in hemodialysis patients: a prospective cohort study","volume":"16","author":"Hsieh","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jvs.2026.08.037_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5551\/jat.65843","article-title":"Chronic limb-threatening ischemia in patients undergoing hemodialysis: epidemiology, risk factors, and outcomes","volume":"33","author":"Komaba","year":"2026","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jvs.2026.08.037_bib20","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jvs.2020.02.041","article-title":"Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia","volume":"72","author":"Khan","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jvs.2024.09.008","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with improved amputation-free survival in chronic limb-threatening ischemia","volume":"81","author":"Elsayed","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jvs.2017.07.130","article-title":"Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention","volume":"67","author":"Bodewes","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","article-title":"ACE inhibitors and survival of hemodialysis patients","volume":"40","author":"Efrati","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvs.2026.08.037_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2313173","article-title":"Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study","volume":"46","author":"Kang","year":"2024","journal-title":"Ren Fail"},{"key":"10.1016\/j.jvs.2026.08.037_bib25","article-title":"Age-Related outcomes after revascularization for chronic limb-threatening ischemia: an analysis of BEST-CLI","volume":"18","author":"Shah","year":"2025","journal-title":"Circ Cardiovasc Interventions"},{"key":"10.1016\/j.jvs.2026.08.037_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jvs.2022.03.013","article-title":"Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population","volume":"76","author":"El Khoury","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jvs.2025.08.037","article-title":"Smoking cessation duration is associated with the risk of amputation after revascularization for chronic limb-threatening ischemia","volume":"83","author":"Carter","year":"2026","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jvs.2025.02.015","article-title":"An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia","volume":"81","author":"Barleben","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jvs.2024.09.026","article-title":"The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial","volume":"81","author":"Ochoa Chaar","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.avsg.2023.10.018","article-title":"Revascularization outcomes stratified by glycemic control in patients with diabetes mellitus and chronic limb-threatening ischemia","volume":"100","author":"Campbell","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.avsg.2024.02.031","article-title":"Clinical implications of low body mass index on endovascular lower extremity revascularization","volume":"106","author":"Pinto Rodriguez","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jvs.2024.03.012","article-title":"Preoperative risk score for mortality within 3 years of visceral segment fenestrated endovascular aortic repair","volume":"80","author":"Penton","year":"2024","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jvs.2025.09.057","article-title":"Preoperative risk score for mortality within 3 years of nonemergent endovascular repair for descending thoracic aortic aneurysm","volume":"83","author":"Khan","year":"2026","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jvs.2024.12.044","article-title":"Risk score for two-year mortality following carotid endarterectomy performed for symptomatic stenosis","volume":"81","author":"Blecha","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.avsg.2026.02.050","article-title":"Preoperative risk Score for mortality within 3 years of elective aortobifemoral artery bypass","volume":"128","author":"Damore","year":"2026","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.08.037_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2026.08.037_bib37","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca Marc","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2026.08.037_bib38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1525-139X.2007.00350.x","article-title":"Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans","volume":"20","author":"Agodoa","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/j.jvs.2026.08.037_bib39","first-page":"620","article-title":"Association of race and age with survival among patients undergoing dialysis","volume":"306","author":"Kucirka","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2026.08.037_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1358863X221140151","article-title":"Demographic and regional trends of peripheral artery disease-related mortality in the United States, 2000 to 2019","volume":"28","author":"Issa","year":"2023","journal-title":"Vasc Med"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426016289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426016289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:39:31Z","timestamp":1792096771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521426016289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"alternative-id":["S0741521426016289"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2026.08.037","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular Quality Initiative-based risk score for mortality within 3 years of revascularization for chronic limb-threatening ischemia in end-stage renal disease patients on dialysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2026.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2026.09.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Vascular Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}